Arkis CerebroFlo™ EVD Catheter with Endexo® Technology


Arkis CerebroFloTM EVD Catheter with Endexo® Technology

The CerebroFlo™ EVD Catheter from Arkis BioSciences is the first and only External Ventricular Drainage catheter with Endexo® Technology, a permanent additive that functionalizes all surfaces, including cut perforations, that greatly reduces fibrinogen and platelet activation and adhesion, resulting in less thrombus formation. Endexo® is a permanent and non-eluting additive extruded into the catheter material, contains no heparin, and remains throughout the life of the catheter without depleting. The CerebroFlo EVD Catheter has demonstrated an average of 99% less thrombus accumulation onto its surface, in-vitro, compared to a market leading EVD catheter. The Endexo® macromolecule has been commercially shown in vascular access, dialysis, and other applications to significantly reduce thrombus related obstructions in a variety of catheters.*

*Data on file, or please reference the CerebroFlo white paper.

Download a brochure.

Download a white paper for in-vitro studies.


View a short educational video for the CerebroFlo EVD Catheter:

Contact Us

Please use the form below to learn more about the Arkis CerebroFlo™ EVD Catheter with Endexo® Technology.

Contact Us

Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)

© 2013-2018  Arkis BioSciences Inc.  All rights reserved.   |   Privacy   |   Sitemap

Go to top